» Articles » PMID: 14584038

Sphingosine 1-phosphate Induces Cell Contraction Via Calcium-independent/Rho-dependent Pathways in Undifferentiated Skeletal Muscle Cells

Overview
Journal J Cell Physiol
Specialties Cell Biology
Physiology
Date 2003 Oct 30
PMID 14584038
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

We have previously shown that sphingosine 1-phosphate (S1P) can induce intracellular Ca(2+) mobilization and cell contraction in C2C12 myoblasts and that the two phenomena are temporally unrelated. Although Ca(2+)-independent mechanisms of cell contraction have been the focus of numerous studies on Ca(2+) sensitization of smooth muscle, comparatively less studies have focused on the role that these mechanisms play in the regulation of skeletal muscle contractility. Phosphorylation and activation of myosin by Rho-dependent kinase mediate most of Ca(2+)-independent contractile responses. In the present study, we examined the potential role of Rho/Rho-kinase cascade activation in S1P-induced C2C12 cell contraction. First, we showed that depletion of Ca(2+), by pre-treatment with BAPTA, did not affect S1P-induced myoblastic contractility, whereas it abolished S1P-induced Ca(2+) transients. These results correlated with the absence of troponin C and with the immature cytoskeletal organization of these cells. Experimental evidence demonstrating the involvement of Rho pathway in S1P-stimulated myoblast contraction included: the activation/translocation of RhoA to the membrane in response to agonist-stimulation in cells depleted of Ca(2+) and the inhibition of dynamic changes of the actin cytoskeleton in cells where Rho functions had been inhibited either by overexpression of RhoGDI, a physiological inhibitor of GDP dissociation from Rho proteins, or by pretreatment with Y-27632, a specific Rho kinase inhibitor. Contribution of protein kinase C in this cytoskeletal rearrangement was also evaluated. However, the pretreatment with Gö6976 or rottlerin, specific inhibitors of PKC alpha and PKC delta, respectively, failed to inhibit the agonist-induced myoblastic contraction. Single particle tracking of G-actin fluorescent probe was performed to statistically evaluate actin cytoskeletal dynamics in response to S1P. Stimulation with S1P was also able to increase the phosphorylation level of myosin light chain II. In conclusion, our results strongly suggest that Ca(2+)-independent/Rho-Rho kinase-dependent pathways may exert an important role in S1P-induced myoblastic cell contraction.

Citing Articles

Is spinal muscular atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications?.

Simone C, Ramirez A, Bucchia M, Rinchetti P, Rideout H, Papadimitriou D Cell Mol Life Sci. 2015; 73(5):1003-20.

PMID: 26681261 PMC: 4756905. DOI: 10.1007/s00018-015-2106-9.


ROCK inhibition as a therapy for spinal muscular atrophy: understanding the repercussions on multiple cellular targets.

Coque E, Raoul C, Bowerman M Front Neurosci. 2014; 8:271.

PMID: 25221469 PMC: 4148024. DOI: 10.3389/fnins.2014.00271.


Controlled heterogeneous stem cell differentiation on a shape memory hydrogel surface.

Han Y, Bai T, Liu W Sci Rep. 2014; 4:5815.

PMID: 25068211 PMC: 5376171. DOI: 10.1038/srep05815.


MLCK-independent phosphorylation of MLC20 and its regulation by MAP kinase pathway in human bladder smooth muscle cells.

Deng M, Ding W, Min X, Xia Y Cytoskeleton (Hoboken). 2010; 68(3):139-49.

PMID: 20722044 PMC: 5664925. DOI: 10.1002/cm.20471.


Sphingosine 1-phosphate increases glucose uptake through trans-activation of insulin receptor.

Rapizzi E, Taddei M, Fiaschi T, Donati C, Bruni P, Chiarugi P Cell Mol Life Sci. 2009; 66(19):3207-18.

PMID: 19662499 PMC: 11115622. DOI: 10.1007/s00018-009-0106-3.